Published in BMC Endocr Disord on October 28, 2011
Factors associated with initiation of antihyperglycaemic medication in UK patients with newly diagnosed type 2 diabetes. BMC Endocr Disord (2012) 0.81
Weight loss surgery for non-morbidly obese populations with type 2 diabetes: is this an acceptable option for patients? Prim Health Care Res Dev (2013) 0.75
Physician reasons for nonpharmacologic treatment of hyperglycemia in older patients newly diagnosed with type 2 diabetes mellitus. Diabetes Ther (2012) 0.75
Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet (2010) 8.27
The role of patient, physician and systemic factors in the management of type 2 diabetes mellitus. Fam Pract (2002) 2.74
Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care (2007) 2.22
Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study. J Diabetes Complications (2008) 1.77
Undertreatment of cardiovascular risk factors among persons with diabetes in the United States. Diabetes Res Clin Pract (2006) 1.31
Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD). Diabetes Care (2009) 1.26
Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1C less than 7%. Diabetes Care (2007) 1.19
Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study. BMC Fam Pract (2009) 1.16
Clinical decisions regarding HbA1c results in primary care: a report from CaReNet and HPRN. Diabetes Care (2004) 1.15
Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study. Clin Ther (2007) 1.10
Time to treatment initiation with oral antihyperglycaemic therapy in US patients with newly diagnosed type 2 diabetes. Diabetes Obes Metab (2011) 0.95
Initiation of glucose-lowering therapy in Type 2 diabetes mellitus patients in general practice. Diabet Med (2004) 0.91
Care of elderly patients with diabetes mellitus: a focus on frailty. Ageing Res Rev (2010) 0.91
Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol (2002) 4.25
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod (2009) 3.74
Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial. Am J Kidney Dis (2013) 2.89
Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses. Clin Pharmacol Ther (2005) 2.85
Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes. J Clin Endocrinol Metab (2006) 2.64
Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia. Eur Heart J (2005) 2.52
Effect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study. Am J Epidemiol (2009) 2.44
Relationship between coronary artery remodeling and plaque vulnerability. Circulation (2002) 2.35
Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol (2002) 2.19
Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome. Med J Aust (2007) 2.03
Health care and productivity costs associated with diabetic patients with macrovascular comorbid conditions. Diabetes Care (2009) 1.97
Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract (2007) 1.81
A review of neuraxial epidural morbidity: experience of more than 8,000 cases at a single teaching hospital. Anesthesiology (2007) 1.80
Improving reproductive performance in overweight/obese women with effective weight management. Hum Reprod Update (2004) 1.73
Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes. Diabetes Care (2011) 1.70
Automated outreach to increase primary adherence to cholesterol-lowering medications. JAMA Intern Med (2013) 1.69
Burden of illness associated with lower urinary tract symptoms including overactive bladder/urinary incontinence. Urology (2009) 1.69
Cost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysis. Int J Chron Obstruct Pulmon Dis (2012) 1.68
Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin Cancer Res (2004) 1.65
Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes. BMC Endocr Disord (2010) 1.60
The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology (2013) 1.56
Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol (2004) 1.51
Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res (2002) 1.42
Oxidative damage to extracellular matrix and its role in human pathologies. Free Radic Biol Med (2008) 1.40
Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension. J Clin Pharmacol (2008) 1.40
Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study. Curr Med Res Opin (2009) 1.39
Quantification of protein modification by oxidants. Free Radic Biol Med (2009) 1.34
Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials. Curr Med Res Opin (2008) 1.28
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis. BMC Endocr Disord (2008) 1.28
Dietary composition of pregnant women is related to size of the baby at birth. J Nutr (2004) 1.23
Roles of tyrosine-rich precursor glycoproteins and dityrosine- and 3,4-dihydroxyphenylalanine-mediated protein cross-linking in development of the oocyst wall in the coccidian parasite Eimeria maxima. Eukaryot Cell (2003) 1.23
EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer. Oncogene (2003) 1.23
Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey study. BMC Res Notes (2011) 1.22
Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid. Biochim Biophys Acta (2006) 1.22
Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care (2005) 1.21
A comparison of dexmedetomidine versus conventional therapy for sedation and hemodynamic control during carotid endarterectomy performed under regional anesthesia. Anesth Analg (2006) 1.20
A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies. Curr Med Res Opin (2007) 1.19
Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis. Cardiovasc Diabetol (2013) 1.17
Diet around conception and during pregnancy--effects on fetal and neonatal outcomes. Reprod Biomed Online (2006) 1.16
Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study. Curr Med Res Opin (2011) 1.16
The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab (2002) 1.14
Photo-oxidation of proteins. Photochem Photobiol Sci (2011) 1.14
Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum (2005) 1.12
Singlet oxygen-mediated protein oxidation: evidence for the formation of reactive side chain peroxides on tyrosine residues. Photochem Photobiol (2002) 1.11
Requirements for superoxide-dependent tyrosine hydroperoxide formation in peptides. Biochem J (2004) 1.11
Early pregnancy loss following assisted reproductive technology treatment. Hum Reprod (2002) 1.11
Hypochlorous acid-mediated protein oxidation: how important are chloramine transfer reactions and protein tertiary structure? Biochemistry (2007) 1.07
Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I. Arterioscler Thromb Vasc Biol (2010) 1.06
Actions of ultraviolet light on cellular structures. EXS (2006) 1.05
Multinational Internet-based survey of patient preference for newer oral or injectable Type 2 diabetes medication. Patient Prefer Adherence (2010) 1.04
Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes. Curr Med Res Opin (2009) 1.03
Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study. Curr Med Res Opin (2012) 1.02
The vinyl ether linkages of plasmalogens are favored targets for myeloperoxidase-derived oxidants: a kinetic study. Biochemistry (2008) 1.02
Radical chemistry of epigallocatechin gallate and its relevance to protein damage. Arch Biochem Biophys (2003) 1.01
Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia. J Am Coll Cardiol (2006) 1.01
Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins. Chem Res Toxicol (2005) 1.01
Association between hypoglycemia and inpatient mortality and length of hospital stay in hospitalized, insulin-treated patients. Curr Med Res Opin (2012) 1.01
Hypochlorite-induced damage to DNA, RNA, and polynucleotides: formation of chloramines and nitrogen-centered radicals. Chem Res Toxicol (2002) 1.00
What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach. Chem Res Toxicol (2009) 0.99
The correlation between allergic rhinitis and sleep disturbance. J Allergy Clin Immunol (2004) 0.99
Kinetic analysis of the reactions of hypobromous acid with protein components: implications for cellular damage and use of 3-bromotyrosine as a marker of oxidative stress. Biochemistry (2004) 0.99
The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophages. Biochem J (2010) 0.98
Hypothiocyanous acid reactivity with low-molecular-mass and protein thiols: absolute rate constants and assessment of biological relevance. Biochem J (2009) 0.97
Protein-bound kynurenine is a photosensitizer of oxidative damage. Free Radic Biol Med (2004) 0.97
Oxidation and inactivation of SERCA by selective reaction of cysteine residues with amino acid peroxides. Chem Res Toxicol (2007) 0.96
Evidence for inactivation of cysteine proteases by reactive carbonyls via glycation of active site thiols. Biochem J (2006) 0.96
Food and nutrient intakes of 9-month-old infants in Adelaide, Australia. Public Health Nutr (2009) 0.95
Hypochlorite-mediated fragmentation of hyaluronan, chondroitin sulfates, and related N-acetyl glycosamines: evidence for chloramide intermediates, free radical transfer reactions, and site-specific fragmentation. J Am Chem Soc (2003) 0.95
Photo-oxidation of cells generates long-lived intracellular protein peroxides. Free Radic Biol Med (2003) 0.95
Hypochlorous acid-mediated oxidation of lipid components and antioxidants present in low-density lipoproteins: absolute rate constants, product analysis, and computational modeling. Chem Res Toxicol (2003) 0.95
Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese males. Br J Clin Pharmacol (2011) 0.94
Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes. Patient Prefer Adherence (2013) 0.94
Hypothiocyanous acid is a more potent inducer of apoptosis and protein thiol depletion in murine macrophage cells than hypochlorous acid or hypobromous acid. Biochem J (2008) 0.94
Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia. Am Heart J (2007) 0.94
Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products. Arch Biochem Biophys (2002) 0.93
Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations. Biochem Pharmacol (2009) 0.93
Removal of amino acid, peptide and protein hydroperoxides by reaction with peroxiredoxins 2 and 3. Biochem J (2010) 0.93
Markers of protein oxidation: different oxidants give rise to variable yields of bound and released carbonyl products. Free Radic Biol Med (2004) 0.93
A survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitus. Diabetes Ther (2015) 0.92
Tryptophan-derived ultraviolet filter compounds covalently bound to lens proteins are photosensitizers of oxidative damage. Free Radic Biol Med (2007) 0.92
Singlet-oxygen-mediated amino acid and protein oxidation: formation of tryptophan peroxides and decomposition products. Free Radic Biol Med (2009) 0.92
Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care (2004) 0.92
Oxidation of DNA, proteins and lipids by DOPA, protein-bound DOPA, and related catechol(amine)s. Toxicology (2002) 0.92
Guanine-specific DNA damage induced by gamma-irradiated histone. Biochem J (2005) 0.92
Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States. Am Heart J (2013) 0.92
Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids. Free Radic Res (2012) 0.92
Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database. Curr Med Res Opin (2010) 0.91
Primary nonadherence to statin therapy: patients' perceptions. Am J Manag Care (2013) 0.91
Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic Res (2009) 0.91
Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan. Matrix Biol (2009) 0.91
Changes in affect and state anxiety across an in vitro fertilization/intracytoplasmic sperm injection cycle. Fertil Steril (2009) 0.91
Detection and characterisation of radicals in biological materials using EPR methodology. Biochim Biophys Acta (2013) 0.90
Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes. Curr Med Res Opin (2015) 0.90